Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in primary progressive multiple sclerosis (PPMS), revealing that it was at least as effective as its ...

Passkeys provide stronger security than traditional passwords and could eventually replace them entirely as adoption grows. We explain everything you need to know and show you how to get started. I ...

Inspired by the shape-shifting skin of octopuses, Penn State researchers developed a smart hydrogel that can change appearance, texture, and shape on command. The material is programmed using a ...

Meta is testing a stand-alone Vibes app, the company confirmed to TechCrunch on Thursday. Launched last September, Vibes lets you create and share short-form AI-generated videos and access a dedicated ...

The Democratic special primary in New Jersey’s 11th Congressional District remains too early to call with progressive Analilia Mejia and former US Rep. Tom Malinowski locked in a tight race. Mejia was ...

The Senate Agriculture Committee on Thursday voted to advance its version of a crypto market structure bill in a party-line vote. The development marks the first time crypto market structure ...

There were a few surprises, and subtle regional digs, as Democratic state parties angled for early spots on the next presidential primary calendar. The New York Times reviewed their applications. By ...

BWC Terminals is investing nearly $316 million to build a new bulk liquid storage facility in Pascagoula, Mississippi. The project is expected to create 25 permanent jobs and represents a significant ...

Project to convert historic Triplett-Day building into The Downtowner faces delays. Owner Robert St John partnered with Dan Hensarling; construction has resumed. Menu to focus on breakfast, ...

Share your feedback and you could win $50. Never miss a story with The Brief, our free newsletter. Keep tabs on Texas politics and policy with our morning newsletter. The Texas Tribune Independent ...

MENLO PARK, Calif. and CINCINNATI, Dec. 3, 2025 /PRNewswire/ -- MyOme, a leading clinical whole-genome testing and polygenic risk modelling (PRS) company, today announced a strategic partnership with ...

Trial tests drug against relapsing form of the disease Drug candidate as effective as Roche's Ocrevus in a separate study Fenebrutinib could bring in over $1 billion in annual peak sales FRANKFURT, ...